Omlyclo News - Latest Updates & Headlines
S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar
Seoul, March 10: Celltrion, a major South Korean biopharmaceutical firm, said on Monday that its biosimilar for asthma and other chronic allergic diseases has obtained approval for sales in the US market.